Global Clinical Trials Industry on Track to Achieve US$ 177.7 Billion by 2033, Showcasing a Resilient 4.41% CAGR Advancement | FMI

The Global Clinical Trials Industry is poised for remarkable growth, with projections indicating a value of US$ 115.4 billion by the end of 2023. According to a comprehensive study by Future Market Insights (FMI), the industry is set to achieve a robust 4.41% Compound Annual Growth Rate (CAGR) as it catapults to an impressive US$ …

Global Clinical Trials Industry Forecasted to Attain US$ 177.7 Billion by 2033, Averaging a 4.41% CAGR Triumph | FMI

By the end of 2023, the Global Clinical Trials Industry is anticipated to be worth US$ 115.4 billion, and it will grow at a CAGR of 4.41% to reach US$ 177.7 billion by the year 2033. Industry sponsors are in the lead with a predicted market share of about 54.7% in 2023, according to a recent …

Global Clinical Trials Industry Set to Surge, Aiming for US$ 177.7 Billion by 2033, at a CAGR of 4.41% | FMI

n a recent study conducted by Future Market Insights (FMI), the Global Clinical Trials Industry is on the verge of remarkable growth. It is projected to reach a valuation of approximately US$ 115.4 billion by the end of 2023 and is poised for further expansion at a robust CAGR of 4.41%. The market’s upward trajectory …